18. A nasopharyngeal aspiration specimen was collected for MERS-CoV laboratory testing on May 19.
Sputum samples from 2 persons who had been in contact with the index patient were also tested for MERS-CoV. Patient 2 was the 63-year-old wife of the index patient; she had had physical contact with him while caring for him during the 3 days of hospitalization. Fever (38°C) and slight oliguria developed in patient 2 on May 19. The other contact, patient 3, was a 78-year-old man who had chronic obstructive pulmonary disease, asthma, and cholangiocarcinoma and who had shared a hospital room with the index patient and had been within 2 meters from him for 4 hours on May 16. Fever (37.8°C) and respiratory symptoms developed in patient 3 on May 20. In the hospital room, the index patient did not undergo any aerosol-generating procedures, but a severe cough developed. The same health care workers cared for the index patient and patient 3.
Laboratory diagnostic methods were performed according to World Health Organization guidelines for molecular detection of MERS-CoV (7-9). To check for contamination derived from the positive control, we designed and synthesized the MERS-CoV real-time reverse transcription PCR (rRT-PCR)-positive transcripts for an upstream MERS-CoV envelope protein gene (upE) and the open reading frame 1a (ORF1a) gene containing 50 bp of a foreign gene (centipede).
Initially, nasopharyngeal samples from the index patient were positive for MERS-CoV by multiplex rRT-PCR. Sputum samples from patients 2 and 3 were also positive, supporting a diagnosis of MERS-CoV infection. Multiplex rRT-PCR results for upE and ORF1a were positive (Table 1) . According to rRT-PCR, the respiratory samples from the 3 patients were negative for 5 other human coronaviruses (SARS-CoV and human CoV-229E, -OC43, -NL63, and -HKU1) and 7 viruses that cause acute respiratory infection (influenza virus A and B; human adenovirus; bocavirus; human parainfluenza virus types 1, 2, and 3; respiratory syncytial virus A and B; human rhinovirus; human metapneumovirus).
For the index patient, MERS-CoV RNA was detectable in sputum, throat swab, and serum samples but not in a urine sample collected 9 days after symptom onset ( Table 1) . The viral load, indicated by cycle threshold values, was high in the lower respiratory tract sample but almost undetectable in the throat swab and serum samples. After sequential sampling repeated every 2-5 days, MERS-CoV RNA was detected in sputum until 44 days after symptom onset, although viral RNA was inconsistently detected and patterns of viral load fluctuated ( Table   Middle East Virus isolation on Vero cells was attempted for each respiratory specimen from the 3 patients. The culture supernatant after inoculation was serially assessed for virus growth by using rRT-PCR and was used for blind passages every 3-7 days after inoculation. After 3 blind passages, cytopathic effect was observed, and we isolated the MERSCoV strain from South Korea (KOR/KNIH/002_05_2015) from the Vero cells after inoculation by using the sputum from patient 2. We constructed a phylogenetic tree by using the general time reversible plus gamma model of the RAxML version 8. 
Conclusions
Because, to our knowledge, cases of MERS-CoV infection in South Korea have not been reported, we had to establish laboratory testing protocols to overcome vulnerabilities in the absence of appropriate epidemiologic support (i.e., generate positive controls to check for contamination and repeat testing). Positive controls containing foreign genes have been generated to check for laboratory contamination. For patients with an unclear exposure history (such as the index patient) and for patients with short exposure durations and unusual clinical symptoms (such as patients 2 and 3), it would be useful if the positive results of rRT-PCR could be confirmed through agarose gel electrophoresis to exclude contamination from the positive control (3, 4) .
The index patient had no history of potential exposure to camels, bats, or their excreta; to symptomatic persons; or to health care workers during his trip to the Middle East, including Saudi Arabia. Although the source of infection for the index patient is unclear, phylogenetic analysis of the whole viral genome showed that the isolate from South Korea was closely related to the MERS-CoV strains isolated in Saudi Arabia in 2015. Because the index patient initially concealed his travel history to Saudi Arabia, United Arab Emirates, and Qatar, MERS-CoV infection was not considered and the patient was not isolated until MERS-CoV infection was suspected 7 days after symptom onset. Meanwhile, other patients and health care workers had multiple opportunities for exposure to the index patient (3-5). The 2 contacts reported here had each been exposed to the index patient. Patient 3 was probably infected via droplet transmission in the hospital room. The hospital room, originally built for 6 persons, had been divided into 2 rooms and lacked ventilation. Furthermore, an air conditioning unit cycled the air in the room with the door and window closed. Thus, poor ventilation might have played a major role in droplet transmission. Detection of MERS-CoV RNA in the respiratory tract varies up to day 33 (11) (12) (13) . In this study, virus was detected in the respiratory tract, inconsistently, for up to 44 days.
Development of effective preventive measures for the MERS-CoV prevention will require systemic and prospective studies associated with viral shedding and use of specimens in addition to those obtained from the respiratory tract to define the kinetics of MERS-CoV. Rapid detection of MERS-CoV, using multiplex rRT-PCR to detect upE and ORF1a genes, would be helpful for countries outside the Arabian Peninsula. 
